New launches to drive Sun Pharma’s future growth; PAT may take a hit by tax surge

Sun Pharma anticipates revenue growth for fiscal year 26, building on an 8% increase in fiscal year 25. However, increased spending on marketing specialty products may impact profitability. Net profit declined in the March quarter due to higher taxes. The com…

Read Full Article →